These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 35693092)

  • 1. Oral administration of TRAIL-inducing small molecule ONC201/TIC10 prevents intestinal polyposis in the
    Madka V; De La Cruz A; Pathuri G; Panneerselvam J; Zhang Y; Stratton N; Hacking S; Finnberg NK; Safran HP; Sei S; Glaze ER; Shoemaker R; Fox JT; Raufi AG; El-Deiry WS; Rao CV
    Am J Cancer Res; 2022; 12(5):2118-2131. PubMed ID: 35693092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small-Molecule ONC201/TIC10 Targets Chemotherapy-Resistant Colorectal Cancer Stem-like Cells in an Akt/Foxo3a/TRAIL-Dependent Manner.
    Prabhu VV; Allen JE; Dicker DT; El-Deiry WS
    Cancer Res; 2015 Apr; 75(7):1423-32. PubMed ID: 25712124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of TRAIL-inducing compounds highlights small molecule ONC201/TIC10 as a unique anti-cancer agent that activates the TRAIL pathway.
    Allen JE; Krigsfeld G; Patel L; Mayes PA; Dicker DT; Wu GS; El-Deiry WS
    Mol Cancer; 2015 May; 14():99. PubMed ID: 25927855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced colon carcinogenesis induced by azoxymethane in min mice occurs via a mechanism independent of beta-catenin mutation.
    Suzui M; Okuno M; Tanaka T; Nakagama H; Moriwaki H
    Cancer Lett; 2002 Sep; 183(1):31-41. PubMed ID: 12049812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ONC201/TIC10 plus TLY012 anti-cancer effects via apoptosis inhibitor downregulation, stimulation of integrated stress response and death receptor DR5 in gastric adenocarcinoma.
    Parker CS; Zhou L; Prabhu VV; Lee S; Miner TJ; Ross EA; El-Deiry WS
    Am J Cancer Res; 2023; 13(12):6290-6312. PubMed ID: 38187068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemoprevention of intestinal adenomatous polyposis by acetyl-11-keto-beta-boswellic acid in APC(Min/+) mice.
    Liu HP; Gao ZH; Cui SX; Wang Y; Li BY; Lou HX; Qu XJ
    Int J Cancer; 2013 Jun; 132(11):2667-81. PubMed ID: 23132636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemopreventive effects of an HDAC2-selective inhibitor on rat colon carcinogenesis and APCmin/+ mouse intestinal tumorigenesis.
    Ravillah D; Mohammed A; Qian L; Brewer M; Zhang Y; Biddick L; Steele VE; Rao CV
    J Pharmacol Exp Ther; 2014 Jan; 348(1):59-68. PubMed ID: 24218540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ONC201 induces cell death in pediatric non-Hodgkin's lymphoma cells.
    Talekar MK; Allen JE; Dicker DT; El-Deiry WS
    Cell Cycle; 2015 Aug; 14(15):2422-8. PubMed ID: 26030065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toll-like receptor 4 regulates spontaneous intestinal tumorigenesis by up-regulating IL-6 and GM-CSF.
    Shi YJ; Zhao QQ; Liu XS; Dong SH; E JF; Li X; Liu C; Wang H
    J Cell Mol Med; 2020 Jan; 24(1):385-397. PubMed ID: 31650683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multitargeted low-dose GLAD combination chemoprevention: a novel and promising approach to combat colon carcinogenesis.
    Mohammed A; Janakiram NB; Brewer M; Vedala K; Steele VE; Rao CV
    Neoplasia; 2013 May; 15(5):481-90. PubMed ID: 23633920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AOM-induced mouse colon tumors do not express full-length APC protein.
    Maltzman T; Whittington J; Driggers L; Stephens J; Ahnen D
    Carcinogenesis; 1997 Dec; 18(12):2435-9. PubMed ID: 9450492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemopreventive efficacy of combined piroxicam and difluoromethylornithine treatment of Apc mutant Min mouse adenomas, and selective toxicity against Apc mutant embryos.
    Jacoby RF; Cole CE; Tutsch K; Newton MA; Kelloff G; Hawk ET; Lubet RA
    Cancer Res; 2000 Apr; 60(7):1864-70. PubMed ID: 10766173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of familial adenomatous polyp development in APC min mice and azoxymethane-induced colon carcinogenesis in F344 Rats by ω-3 fatty acid rich perilla oil.
    Rao CV; Patlolla JM; Cooma I; Kawamori T; Steele VE
    Nutr Cancer; 2013; 65 Suppl 1():54-60. PubMed ID: 23682783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of dietary apigenin on colonic ornithine decarboxylase activity, aberrant crypt foci formation, and tumorigenesis in different experimental models.
    Au A; Li B; Wang W; Roy H; Koehler K; Birt D
    Nutr Cancer; 2006; 54(2):243-51. PubMed ID: 16898869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic and Pharmacological Screens Converge in Identifying FLIP, BCL2, and IAP Proteins as Key Regulators of Sensitivity to the TRAIL-Inducing Anticancer Agent ONC201/TIC10.
    Allen JE; Prabhu VV; Talekar M; van den Heuvel AP; Lim B; Dicker DT; Fritz JL; Beck A; El-Deiry WS
    Cancer Res; 2015 Apr; 75(8):1668-74. PubMed ID: 25681273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemoprevention of intestinal polyposis in the Apcdelta716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor.
    Oshima M; Murai N; Kargman S; Arguello M; Luk P; Kwong E; Taketo MM; Evans JF
    Cancer Res; 2001 Feb; 61(4):1733-40. PubMed ID: 11245490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. R-flurbiprofen chemoprevention and treatment of intestinal adenomas in the APC(Min)/+ mouse model: implications for prophylaxis and treatment of colon cancer.
    Wechter WJ; Kantoci D; Murray ED; Quiggle DD; Leipold DD; Gibson KM; McCracken JD
    Cancer Res; 1997 Oct; 57(19):4316-24. PubMed ID: 9331093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of intestinal polyps in Msh2-deficient and non-Msh2-deficient multiple intestinal neoplasia mice by a specific cyclooxygenase-2 inhibitor and by a dual cyclooxygenase-1/2 inhibitor.
    Lal G; Ash C; Hay K; Redston M; Kwong E; Hancock B; Mak T; Kargman S; Evans JF; Gallinger S
    Cancer Res; 2001 Aug; 61(16):6131-6. PubMed ID: 11507063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First-In-Class Small Molecule ONC201 Induces DR5 and Cell Death in Tumor but Not Normal Cells to Provide a Wide Therapeutic Index as an Anti-Cancer Agent.
    Allen JE; Crowder RN; El-Deiry WS
    PLoS One; 2015; 10(11):e0143082. PubMed ID: 26580220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of 5-aminosalicylic acid (5-ASA) for cancer chemoprevention: lack of efficacy against nascent adenomatous polyps in the Apc(Min) mouse.
    Ritland SR; Leighton JA; Hirsch RE; Morrow JD; Weaver AL; Gendler SJ
    Clin Cancer Res; 1999 Apr; 5(4):855-63. PubMed ID: 10213222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.